文献速递肾小球疾病

肾小球疾病试验的核心结局集:肾脏病标准化结局-肾小球疾病(SONG-GD)利益相关者研讨会报告

A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops.
PubMed 文献 · Clin J Am Soc Nephrol · 2021-12-30

SONG-GD initiative在澳大利亚墨尔本和美国华盛顿特区举办了两场1.5小时研讨会,50名患者/照护伙伴和来自19个国家的88名卫生专业人员参加,通过主题分析确定了支持核心结局的主题,并确立了肾脏功能、疾病活动、死亡、生活参与和心血管疾病为成人肾小球疾病试验的核心结局。

要点

  • 研讨会确立肾脏功能、疾病活动、死亡、生活参与和心血管疾病为成人肾小球疾病试验的核心结局。
  • 支持核心结局的主题包括限制疾病进展、稳定与控制、确保普遍相关性。
  • 未来工作需要为每个域建立核心测量指标,资助者和监管机构对核心结局集的采纳至关重要。

核心结论

  • 研讨会主题显示对肾脏功能、疾病活动、死亡、生活参与和心血管疾病的支持,这些被确立为成人肾小球疾病试验的核心结局。

研究设计与样本

  • 在澳大利亚墨尔本和美国华盛顿特区举办了两场1.5小时的研讨会。
  • 通过目的性抽样确定了50名患者/照护伙伴和来自19个国家的88名卫生专业人员参加;51%为女性。
  • 患者和照护伙伴来自美国、澳大利亚和加拿大,具有系统性特征肾小球疾病(n=9)、肾脏局限性肾病综合征(n=9)或其他肾脏局限性肾小球疾病(n=8)的经验。

主要发现

  • 识别出三个支持拟议核心结局的主题:限制疾病进展、稳定与控制、确保普遍相关性(即适用于不同人群和环境)。
  • 第四个主题为实施准备,包括与资助者和监管机构接触、建立可靠且经过验证的测量方法、利用患者报告结局的现有认可。

关键数值与推荐

  • 核心结局:肾脏功能、疾病活动、死亡、生活参与、心血管疾病。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 未来工作需要为每个域建立核心测量指标,资助者和监管机构对核心结局集在试验中的采纳至关重要。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Outcomes reported in trials in adults with glomerular disease are often selected with minimal patient input, are heterogeneous, and may not be relevant for clinical decision making. The Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) initiative aimed to establish a core outcome set to help ensure that outcomes of critical importance to patients, care partners, and clinicians are consistently reported. DESIGN, SETTING, PARTICIPANTS, AND MEASUREMENTS: We convened two 1.5-hour workshops in Melbourne, Australia, and Washington, DC, United States. Attendees were identified purposively with 50 patients/care partners and 88 health professionals from 19 countries; 51% were female. Patients and care partners were from the United States, Australia, and Canada, and had experience of a glomerular disease with systemic features (n=9), kidney-limited nephrotic disease (n=9), or other kidney-limited glomerular disease (n=8). Attendees reviewed the results of the SONG-GD Delphi survey and aims of the workshop and then discussed potential core outcomes and their implementation in trials among moderated breakout groups of eight to 12 people from diverse backgrounds. Transcripts of discussions were analyzed thematically. RESULTS: Three themes were identified that supported the proposed core outcomes: limiting disease progression, stability and control, and ensuring universal relevance (i.e., applicable across diverse populations and settings). The fourth theme, preparedness for implementation, included engaging with funders and regulators, establishing reliable and validated measures, and leveraging existing endorsements for patient-reported outcomes. CONCLUSIONS: Workshop themes demonstrated support for kidney function, disease activity, death, life participation, and cardiovascular disease, and these were established as the core outcomes for trials in adults with glomerular disease. Future work is needed to establish the core measures for each domain, with funders and regulators central to the uptake of the core outcome set in trials.

来源:Clin J Am Soc Nephrol,查看原文。版权归原作者所有。

引用

  1. Carter SA, Lightstone L, Cattran D, et al. A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops. Clin J Am Soc Nephrol. 2021. PMID: 34969698. doi:10.2215/CJN.07840621

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。